ERBB2 and breast cancer: Currently, a phase II clinical trial (NCT03331601) to evaluate its potential for detecting brain metastases in BC patients and a phase II clinical trial (NCT03924466) to evaluate the correlation between image-based HER2 quantification in the uptake of 68Ga-NOTA-2Rs15d in local or distant metastasis in BC patients are all in progress.